B-SAFE: French drink drug detection innovation
B-SAFE: the drug detector pen for drinks that can change party prevention
Bars, clubs, festivals, BDE, associations, local authorities: the issue is no longer just raising awareness about chemical submission, but having a concrete protocol when a drink seems suspicious.
B-SAFE, developed by LUEUR and offered exclusively by AMA Prévention, is a French device for detecting drugs in drinks, designed for field professionals.
Why B-SAFE arrives at the right time
Chemical submission has become a key issue for public venues, event organizers, student associations, and local authorities. Awareness campaigns and training are essential, but they don’t always answer a concrete question: what to do when someone thinks their drink has been tampered with?
B-SAFE provides an operational solution: a drug detector pen for drinks, visible, reusable, made in France, and suitable for professional use.
A tool designed to test a suspicious drink directly on site.
Up to 5,000 uses, for a long lifespan according to manufacturer information.
A device that helps structure an anti-chemical submission protocol.
How does B-SAFE work?
B-SAFE comes in the form of a detection pen. Its goal is to help identify the possible presence of unwanted substances in a drink without turning every establishment into a lab.
It is intended for professionals and trained teams: bar staff, security managers, organizers, student associations, prevention volunteers, or communities.
Which drugs and substances can B-SAFE detect?
B-SAFE’s strength is its multi-substance approach. According to available manufacturer information, B-SAFE can help detect several substance families, including:
- GHB, often linked to the risks of drugged drinks;
- benzodiazepines, sedative medications frequently cited in chemical submission cases;
- sedative medicinal substances ;
- products used in chemical submission ;
- up to 30 products, drugs, and medications according to public/manufacturer data.
Why bars, clubs, festivals, and communities should use B-SAFE
An establishment cannot promise zero risk. However, it can show it takes the issue seriously with a clear system: information, training, point of contact, preservation of useful elements, and a testing solution.
Create a simple protocol for suspicious drinks.
Equip prevention, first aid, security posts, or trained volunteers.
Strengthen student parties with a visible solution.
Frequently asked questions about B-SAFE
Does B-SAFE only detect GHB?
No. B-SAFE is presented as a multi-substance detection device targeting notably GHB, benzodiazepines, and several substances associated with chemical submission.
Does B-SAFE replace laboratory analysis?
No. It is a field aid to quickly test a suspicious drink. It does not replace toxicological analysis, medical advice, or emergency care.
Who is B-SAFE for?
For bars, clubs, festivals, event organizers, BDE, associations, communities, and organizations wishing to strengthen their anti-chemical submission protocol.
Buy B-SAFE directly on the product page
Do you manage a bar, club, festival, association, or community? B-SAFE can become a practical tool in your protocol for preventing drugs in drinks.
Which substances can be detected in a drink?
Chemical submission is not limited to GHB. Reported cases may involve sedatives, anxiolytics, antihistamines, opioids, or drug mixtures. This is precisely why a modern prevention approach must address drugs in drinks, not just anti-GHB.
Type 1 benzodiazepines
The “-pam” family: diazepam/Valium, oxazepam/Séresta, lormetazepam, bromazepam/Lexomil, clonazepam/Rivotril, lorazepam, flunitrazepam, nordazepam, loprazolam/Havlane, chlorazepate/Tranxène, prazepam/Lysanxia, nitrazepam, temazepam, chlordiazepoxide. Noted exception: clobazam.
Type 2 benzodiazepines
The “-lam” family: alprazolam/Xanax, midazolam, triazolam, estazolam and related molecules.
Synthetic benzodiazepines
Bromazolam, etizolam, bentazepam, bromonordiazepam/desalkylgidazepam, flubrotizolam, fluclotizolam, gidazepam, methylclonazepam, norflurazepam/desalkylflurazepam, thionordazepam/demethylsulazepam, tofisopam/Emandaxin.
Other relevant families
Antihistamines and phenothiazines: pheniramine/Fervex, cyamemazine, alimemazine/Théralène, levomepromazine/Nozinan, chlorpromazine/Largactil, promethazine. Opioids: codeine, morphine, oxycodone and related opioids, with caution regarding pure tramadol. Other substances: GHB, ecstasy/MDMA, and certain cutting drugs.
Important note: this information should be read as an aid for prevention and choosing risk reduction tools. A drink test does not replace collective vigilance, medical care, or sampling performed in a medico-legal context. Antipsychotics such as olanzapine, clozapine, or quetiapine are mentioned as a family to be confirmed.
Prevention FAQ: drink tests, GHB, and chemical submission
Is an anti-GHB product enough to cover the risk?
No. GHB is highly publicized, but chemical submission can also involve benzodiazepines, sedative antihistamines, opioids, ecstasy/MDMA, or mixtures. A prevention strategy must therefore address drug detection in drinks more broadly.
Why combine B-SAFE with Test Ton Verre bracelets or cards?
Uses differ: cards and bracelets are simple, accessible, and suited for event distribution; B-SAFE offers a broader and premium approach for individuals, venues, or organizers who want to strengthen control over a suspicious drink.
What to do in case of discomfort or doubt?
Ensure the person’s safety, do not leave them alone, alert those around or staff, contact emergency services if necessary, and keep the glass if analysis might be useful. The test is a prevention tool, not a medical diagnosis.
Scientific validation of B-SAFE
The B-SAFE project, a drug detector pen for drinks, is validated and supported by Professor Jean-Claude Alvarez, toxicologist, professor of pharmacology-toxicology, and director of the toxicology laboratory at CHU Raymond-Poincaré/AP-HP in Garches.
A leading authority in toxicology, he is associated with the reference work conducted in France on psychoactive substances and chemical submission, in a national ecosystem also supported in public debate by voices such as Sandrine Josso and Caroline Darian.
This validation strengthens B-SAFE's technological positioning and the accuracy of its detection for drug prevention in drinks. Discover the B-SAFE product sheet.
